Benefits2-opt.jpgBlood cancers

On 1 July 2017 the management of the Royal Liverpool University Hospital haemato-oncology service and its 120 members of staff transferred to The Clatterbridge Cancer Centre, bringing together the care of people with blood cancers with care for solid tumours for the first time in the region. The outpatient, inpatient and day case haemato-oncology services will continue to be delivered in their current location within The Royal Liverpool University Hospital before moving into Clatterbridge Cancer Centre – Liverpool in 2020.

This means that people from Liverpool with proven or suspected blood cancer will continue to receive their treatment (and investigations) as they do now but in 2020 will benefit from:

  • Access to the highest level of medical expertise, while still being able to have their treatment locally wherever possible;
  • Equity of access with patients who have solid tumours to the best cancer support care including counselling, psychological and peer support, financial advice and therapies; and Enhanced access to innovative treatments through clinical trials.

The Clatterbridge Cancer Centre is currently working on further proposals to improve care by bringing services into the community and expanding The Clatterbridge Cancer Centre’s chemotherapy at home service to include haemato-oncology patients.  ​​